Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Female patients aged between 18-30 years. Patients with a chief complaint of painful menstruation for at least two consecutive cycles. Patients with a regular menstrual cycle Patients willing to provide informed written consent.
Exclusion criteria
Exclusion criteria: Patients with congenital anomalies of the reproductive tract. Patients with blood coagulopathy disorders. Patients with pathological conditions like DUB, PID, IUCD, or endometriosis. Patients diagnosed with any malignancy. Patients diagnosed with fibroid uterus or adenomyosis. Patients with chronic general illnesses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess and compare the effect of drchurna and Hingu churna in the management of kashtartava by using subjective and objective criteriaTimepoint: Day 21 to 28 drug administration for 2 consecutive cycles Day 1 and 2 of 3rd cycle - assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess whether chaturbeej churna is more effective than hingu churna in management of udavarta yonivyapadTimepoint: statisticall evaluation at the end of trial | — |
Countries
India
Contacts
Ashvin rural Ayurved college, Manchi Hill, Ashvin, sangamner